PHENOBARBITAL Sodium Injection
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
14,806 recalls, newest first
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.
Defective container
Defective container
Defective container
Defective container
Defective container
Defective container
Labeling: Label Mix-Up
FAILED CONTENT UNIFORMITY SPECIFICATIONS
CGMP Deviations: FDA analysis found product to contain acetal and acetaldehyde above specification limits.
Labeling: Label mix-up: Incorrect label placed on product. Shipper cases labeled Meclizine Hydrochloride Tablets contain bottles incorrectly labeled as PredniSONE Tablets. The tablets in the bottles are Meclizine Hydrochloride
Super Potent and Failed Reconstitution Time
Sub Potent
Sub Potent
Super Potent
Sub Potent
Product found to be Sub Potent or Exceeded reconstitution time
Subpotent Drug
Subpotent Drug
Subpotent Drug
Subpotent Drug